Development of nanoemulsions containing penciclovir for herpes simplex treatment and a liquid chromatographic method to drug assessment in porcine skin layers
DOI:
https://doi.org/10.22456/2527-2616.103121Keywords:
penciclovir, nanoemulsion, cutaneous delivery studies, LC method validation, porcine skinAbstract
A successful formulation (penciclovir hydrogel nanoemulsion - HN) to be used in transdermal drug delivery route to treat herpes simplex virus was developed and an analytical method to quantify penciclovir (PCV) in porcine ear skin was stablished and validated. PCV nanoemulsions were prepared by high pressure homogenization and presented spherical mean droplet size 180 nm. The association efficiency and zeta potential were 87% and– 27 mV, respectively. The bioanalytical method developed showed specificity for the interferences from the skin matrixes (epidermis and dermis) and the linearity was in the range 0.1 – 25 μg/mL of drug, The mean recovery data for the three levels tested were 95.2% for the epidermis and 97.3% for the dermis and adequate results were obtained for repeatability and inter-day precision. In vitro percutaneous absorption studies with the PCV nanoemulsion and a market cream were conducted employing the porcine skin.The cumulative amounts of PCV permeated from cream and HN, 8 h after dosing, were 2.60 and 4.15 μg/cm², respectively, representing a quite higher flux and a much higher permeability coefficient for the developed formulation. It can be concluded that HN provide a good skin targeting effect and may be a promising carrier for topical delivery of penciclovir.
Downloads
References
Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ. Topical application of penciclovir cream for the treatment of herpes simplex facialis / labialis : a controlled trial BACKGROUND : 2002;67–72.
Yu A, Guo C, Zhou Y, Cao F, Zhu W, Sun M, et al. International Immunopharmacology Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovirloaded microemulsion. Int Immunopharmacol [Internet]. 2010;10(10):1305–9. Available from: http://dx.doi.org/10.1016/j.intimp.2010.07.015
Hasler-nguyen N, Shelton D, Ponard G, Bader M, Schaffrik M, Mallefet P. penciclovir 1 % cream and acyclovir 5 % cream used to treat herpes simplex virus infection. 2009;10:1–10.
Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. 2009;372:191–8.
Lopes CM, Silva J, Real Oliveira MECD, Lúcio M. Lipidbased colloidal carriers for topical application of antiviral drugs. In: Design of Nanostructures for Versatile Therapeutic Applications. 2018. p. 565–622.
Sadurní N, Solans C, Azemar N, García-Celma MJ. Studies on the formation of O/W nano-emulsions, by lowenergy emulsification methods, suitable for pharmaceutical applications. Eur J Pharm Sci. 2005;26(5):438–45.
Solans C, Izquierdo P, Nolla J, Azemar N. Nanoemulsions. 2005;10:102–10.
Almeida ME, Teixeira HF, Koester LS. Preparação de Emulsões Submicrométricas : Aspectos Teóricos sobre os Métodos Empregados na Atualidade. 2008;27(5):780–8.
Pu X, Sun J, Li M, He Z. Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs. 2009;(59):417–27.
Mehnert W, Mäder K. Solid lipid nanoparticles ☆ Production , characterization and applications. Adv Drug Deliv Rev [Internet]. 2012;64:83–101. Available from: http://dx.doi.org/10.1016/j.addr.2012.09.021
Jensen LB, Petersson K, Nielsen HM. European Journal of Pharmaceutics and Biopharmaceutics In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm [Internet]. 2011;79(1):68–75. Available from: http://dx.doi.org/10.1016/j.ejpb.2011.05.012
Trimaille T, Chaix C, Delair T, Pichot C, Teixeira H, Dubernet C, et al. Interfacial deposition of functionalized copolymers onto nanoemulsions produced by the solvent displacement method. Colloid Polym Sci. 2001;279(8):784–92.
Schäfer-korting M, Mehnert W, Korting H. Lipid nanoparticles for improved topical application of drugs for skin diseases ☆. 2007;59:427–43.
Jardim MRCBGBCHCICSF. Revisão - Validação de métodos cromatográficos e eletroforéticos. Quim Nova. 2004;27(5):771–80.
Barth AB, Pereira RL, Vargas BA De, Volpato NM. A simple and rapid method to assess butena fi ne hydrochloride in skin samples and a comparative cutaneous retention study of two marketed formulations. 2010;(October).
Fda CC. Guidance for Industry Q2B Validation of Analytical Procedures : Methodology. 1800;(November 1996).
Mehnert W, Mader K. Solid lipid nanoparticles Production , characterization and applications. 2001;47:165–96.
Henning A, Schaefer UF, Neumann D. Potential pitfalls in skin permeation experiments: Influence of experimental factors and subsequent data evaluation. Eur J Pharm Biopharm [Internet]. 2009;72(2):324–31. Available from: http://dx.doi.org/10.1016/j.ejpb.2008.07.016
Patravale VB, Date AA, Kulkarni RM. Nanosuspensions : a promising drug delivery strategy. 2004;(1992):827–40.
20. Müller RH, Schmidt S, Buttle I, Akkar A, Schmitt J, Brömer S. SolEmuls® - Novel technology for the formulation of i.v. emulsions with poorly soluble drugs. Int J Pharm. 2004;269(2):293–302.
Lee CH, Moturi V, Lee Y. Thixotropic property in pharmaceutical formulations. J Control Release [Internet]. 2009;136(2):88–98. Available from: http://dx.doi.org/10.1016/j.jconrel.2009.02.013
Downloads
Published
Versions
- 12-03-2026 (2)
- 16-07-2020 (1)
How to Cite
Issue
Section
License
Copyright (c) 2020 Drug Analytical Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.





